Jane S. Ricciuti, RPh, MS

Disclosures

January 29, 2004

In This Article

Anti-infective Agents

VFEND
(voriconazole) Tablets & Injection

Manufacturer: Pfizer, Inc.

Drug Approval Classification: Original New Drug Application (Approval Date: 11/14/03)

New Indication: This new drug application provides for the use of VFEND (voriconazole) tablets and intravenous injection for esophageal candidiasis.

VFEND (voriconazole) Tablets & Injection Labeling

Medscape DrugInfo

VFEND (voriconazole) Tablets & Injection

processing....